Bristol-Myers Squibb - 28 Year Dividend Yield History | BMY

Historical dividend payout and yield for Bristol-Myers Squibb (BMY) since 1990. The current TTM dividend payout for Bristol-Myers Squibb (BMY) as of October 22, 2018 is $1.60. The current dividend yield for Bristol-Myers Squibb as of October 22, 2018 is 2.95%.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $88.755B $20.776B
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $373.058B 17.49
Pfizer (PFE) United States $264.902B 15.51
Novartis AG (NVS) Switzerland $202.059B 17.26
Merck (MRK) United States $195.069B 17.23
AbbVie (ABBV) United States $133.211B 13.01
Eli Lilly (LLY) United States $120.201B 22.25
Sanofi (SNY) France $111.785B 14.15
Novo Nordisk (NVO) Denmark $105.487B 16.86
GlaxoSmithKline (GSK) United Kingdom $101.355B 13.53
AstraZeneca (AZN) United Kingdom $99.315B 10.92